Meestro: $4.5B valuation, IPO Readiness 49, Public. Filed S-1 with the SEC on June 2026 — IPO actively in progress. Track live on The IPO Stack.
Meestro provides embedded finance infrastructure for healthcare practices, enabling doctors, dentists, and healthcare providers to offer patient financing, payment plans, and revenue cycle management within their existing software. Valued at 100M USD with 30M raised, Meestro serves 10K+ healthcare practices and competes with CareCredit and Cherry Financing.
Scores, valuations, and IPO signals for the companies that matter. 5-minute read, every Tuesday.
Top companies most likely to IPO in 2026, ranked by IPO Readiness Score.
Track Meestro IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.
Meestro is already a public company.
Meestro is valued at $4.5B as of the most recent funding round. This valuation is based on its most recent private funding round tracked by TechStackIPO.
Meestro is already a public company. You can invest by purchasing shares on public stock exchanges.
Meestro scores 49/100 (Grade: D) on TechStackIPO's IPO Readiness Index. The score evaluates funding scale, valuation trajectory, funding momentum, stage progression, and company maturity. Scores above 70 indicate strong near-term IPO potential.
Yes — Meestro filed an S-1 registration statement with the SEC on June 12, 2026, indicating an active IPO process.
Meestro has raised $580M in total venture capital and private equity funding.